Professor Gillian Leng to retire from NICE

9 September 2021 - Professor Leng has spent more than 20 years working at NICE. ...

Read more →

NICE signs up to join the GetReal Institute

28 April 2021 -NICE’s ambition complements the GetReal Institute’s core mission to facilitate the adoption and implementation of real-world evidence ...

Read more →

Ovarian cancer patients to have NICE approved drug combination option on Cancer Drugs Fund

19 March 2021 - A potentially life-extending drug combination for some people with advanced, high-grade epithelial ovarian, fallopian tube or primary ...

Read more →

Modified COVID-19 vaccines for variants to be fast-tracked, says MHRA and other regulators

4 March 2021 - Future vaccine modifications that respond to new variants of coronavirus to be made available quickly to UK recipients, without compromising on safety, ...

Read more →

NICE talking to you: trends in early HTA engagement

29 October 2020 - In 2009, NICE was one of the first health technology assessment agencies to offer the opportunity ...

Read more →

Keeping pace with pharmaceutical innovation: the importance of the NICE methods review

19 August 2020 - The NICE plays a vitally important role in ensuring patients get timely access to new medicines ...

Read more →

NICE publishes guidance on Astellas' Xospata

17 August 2020 - The National Institute for Health and Care Excellence has now published final guidance backing NHS use ...

Read more →

Elmiron bags draft NICE approval

10 October 2019 - NICE has published a draft final appraisal regarding Elmiron (pentosan polysulfate sodium) for bladder pain syndrome. ...

Read more →

Advancing patient engagement

2 October 2019 - It’s widely accepted that seeking patient input into their health and care improves outcomes for them and ...

Read more →

NICE to co-host 2021 HTAi Annual Meeting in Manchester

18 June 2019 - Health Technology Assessment International (HTAi) has announced that NICE has been chosen as co-hosts of their 2021 ...

Read more →

NICE nod for breast cancer delay drug

2 April 2019 - NICE has recommended Eli Lilly’s Verzenio (abemaciclib) when given with Faslodex (fulvestrant), to be available for ...

Read more →

The FDA announces Patient Engagement Advisory Committee meeting on utilising real world data from patient-driven platforms that connect and empower patients

21 September 2018 - On 15 November 2018, the FDA’s Patient Engagement Advisory Committee will hold its second public meeting ...

Read more →

Building synergy between regulatory and HTA agencies beyond processes and procedures—can we effectively align the evidentiary requirements? A survey of stakeholder perceptions

13 June 2018 - The pathway for bringing a new medicine to the market is dependent on two sequential processes: achieving ...

Read more →

Patient empowerment in Europe: is no further research needed?

15 May 2018 - In economic theory, health care can be considered a clear example of ‘market failure’ caused by ...

Read more →

Deputy Ministers call out patient engagement as key to transforming health care

17 April 2018 - The 2018 CADTH Symposium officially kicked off in Halifax with a panel of senior healthy policy ...

Read more →